Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
LeMaitre Vascular, Inc. (LMAT) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2026-06-30, revenue was 262.4m $, net income was 65.7m $. Distributions over the trailing twelve months were 1 $ per share. Payouts have run for 13 consecutive years.
This summary is compiled automatically from SEC filings and exchange data.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
LeMaitre Vascular, Inc. (LMAT) is a company in the Health care sector; its shares trade on Nasdaq.
The price of LeMaitre Vascular, Inc. (LMAT) on October 30, 2026 is 81.08 $, −4.91 % on the day. Over 52 weeks the stock traded between 78.22 $ and 118.01 $; the price now sits 7 % of the way up that range. Over the past year the price changed by −5.45 %. The P/E ratio is 28.23, which is above the sector median (24.61). Market capitalization is 1.85 billion $, rank 26 among 100 stocks of the same industry with a known capitalization.
LeMaitre Vascular, Inc. trades on Nasdaq under the ticker LMAT. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks LMAT has traded between 78.22 $ and 118.01 $. As of 30 October 2026 the price stood 11.06 % of the way from the 52-week low to the high.
Over one year LMAT shares fell 5.45 %; over six months they fell 28.04 %. Volatility over 90 days is 56.95 %. Dividends are not included: this is price change only, as of 30 October 2026.
LMAT trades at a price-to-earnings ratio of 28.2, above the sector median of 24.6. Price to sales is 7.1, above the sector median of 3.6. Price to book is 4.4, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
LeMaitre Vascular, Inc. reported revenue of 262M $ and net income of 66M $ over the last four quarters. Net margin is 25.02 %. Revenue changed by +11.85 % year over year. Earnings per share are 2.86 $. Market capitalisation is 1.9B $.
LMAT has a return on equity of 15.62 %, above the sector median of −40.58 %. Return on assets is 10.25 %, above the sector median of −30.08 %. Operating margin is 29.46 %, above the sector median of −20.96 %.
LeMaitre Vascular, Inc. pays dividends quarterly: 0.95 $ per share over the past twelve months, a yield of 1.17 %. The latest payment was 0.25 $, with an ex-dividend date of 20 August 2026. The company has raised its payout for 12 years in a row.